Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-129274
Filing Date
2024-11-20
Accepted
2024-11-20 16:17:25
Documents
65
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q sepn-20240930.htm   iXBRL 10-Q 2967543
2 EX-31.1 sepn-ex31_1.htm EX-31.1 17149
3 EX-31.2 sepn-ex31_2.htm EX-31.2 16971
4 EX-32.1 sepn-ex32_1.htm EX-32.1 15906
5 GRAPHIC img117579907_0.jpg GRAPHIC 60474
  Complete submission text file 0000950170-24-129274.txt   9409960

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sepn-20240930.xsd EX-101.SCH 1095389
68 EXTRACTED XBRL INSTANCE DOCUMENT sepn-20240930_htm.xml XML 1496866
Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Filer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42382 | Film No.: 241480620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)